1. AB0360 EFFICACY AND SAFETY OF THE PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST CR6086 ADDED TO METHOTREXATE IN DMARD-NAÏVE EARLY RA PATIENTS: A PHASE 2 RANDOMIZED CONTROLLED TRIAL. (2nd June 2020) Authors: Pavelka, K.; Delina, I. D.; Mazur, M.; D'amato, M.; Giacovelli, G.; Girolami, F.; Krogulec, M.; Østgård, R.; Bihlet, A. R.; Kubassova, O.; Rovati, L.; Taylor, P. C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CR4056, a first-in-class imidazoline-2 receptor ligand analgesic, in pain from knee osteoarthritis phenotypes: a randomized, placebo-controlled, double-blind, phase iia clinical trial. (April 2018) Authors: Rovati, L.; Probert, N.J.; Blicharski, T.; Brambilla, N.; Vitalini, C.; Girolami, F.; Giacovelli, G.; D'Amato, M. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial. Issue 1 (January 2020) Authors: Rovati, L.C.; Brambilla, N.; Blicharski, T.; Connell, J.; Vitalini, C.; Bonazzi, A.; Giacovelli, G.; Girolami, F.; D'Amato, M. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Stakeholders' opinions and expectations for the forest-based sector: a regional case study in Italy. (1st March 2017) Authors: Paletto, A.; Giacovelli, G.; Pastorella, F. Journal: International forestry review Issue: Volume 19:Number 1(2017:Mar.) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗